Displaying One Session

View
Alicante Auditorium (Hall 3)

Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC

Date
28.09.2019
Time
13:00 - 14:30
Chairs
  • Nadia Harbeck (Munich, Germany)
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC Industry Satellite Symposium

Introduction (ID 6351)

Lecture Time
13:00 - 13:05
Speakers
  • Nadia Harbeck (Munich, Germany)
Session Name
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC
Location
Alicante Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
28.09.2019
Time
13:00 - 14:30
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC Industry Satellite Symposium

Case presentation: Consideration of initial combination therapy with CDK 4/6 inhibitors (ID 6361)

Lecture Time
13:05 - 13:10
Speakers
  • Sara M. Tolaney (Boston, MA, United States of America)
Session Name
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC
Location
Alicante Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
28.09.2019
Time
13:00 - 14:30
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC Industry Satellite Symposium

Panel Discussion: Clinical efficacy and safety data of upfront combination therapy used in HR-positive/HER2-negative MBC (ID 6354)

Lecture Time
13:10 - 13:35
Session Name
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC
Location
Alicante Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
28.09.2019
Time
13:00 - 14:30
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC Industry Satellite Symposium

Case continuation: Addition of CDK4/6 inhibitor therapy upon initial endocrine therapy progression (ID 6356)

Lecture Time
13:35 - 13:40
Speakers
  • Nadia Harbeck (Munich, Germany)
Session Name
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC
Location
Alicante Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
28.09.2019
Time
13:00 - 14:30
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC Industry Satellite Symposium

Panel discussion: Clinical efficacy and safety data of CDK 4/6 inhibitor therapy after progression on initial endocrine therapy in HR-positive/HER2-negative MBC (ID 6359)

Lecture Time
13:40 - 14:05
Session Name
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC
Location
Alicante Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
28.09.2019
Time
13:00 - 14:30
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC Industry Satellite Symposium

Case Follow-up: Management of CDK 4/6 Inhibitor Therapy Toxicities (ID 6363)

Lecture Time
14:05 - 14:10
Speakers
  • Valentina Guarneri (Padova, Italy)
Session Name
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC
Location
Alicante Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
28.09.2019
Time
13:00 - 14:30
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC Industry Satellite Symposium

Panel Discussion: Differentiation of dosing administration, monitoring, and mitigation of AEs for CDK 4/6 inhibitor therapy (ID 6364)

Lecture Time
14:10 - 14:25
Session Name
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC
Location
Alicante Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
28.09.2019
Time
13:00 - 14:30
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC Industry Satellite Symposium

Concluding Remarks and Audience Q&A (ID 6365)

Lecture Time
14:25 - 14:30
Speakers
  • Nadia Harbeck (Munich, Germany)
Session Name
Medscape Oncology- The ABCs of CDK 4/6 Inhibitors: Who, when, and why in HR-positive/HER2-negative MBC
Location
Alicante Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
28.09.2019
Time
13:00 - 14:30